研究队伍     首页 > 研究队伍
何永捍   研究员
衰老调控与功能研究学科组
职  务: 衰老调控与功能研究学科组 负责人
学  历:
电  话: +86-871-65118976
传  真:
电子邮件: heyonghan@mail.kiz.ac.cn
通讯地址: 云南省昆明市盘龙区龙欣路17号425室    650201
其他主页: https://orcid.org/0000-0003-4409-4590
CASKIZ-IR(机构知识库)个人主页
  简  历

何永捍,医学博士,研究员,博士生导师。长期从事衰老及衰老相关疾病的功能研究和活性小分子药物研发,已在Nature Communications、Journal of Hematology & Oncology、Aging CellJournal of controlled release等国际核心刊物上发表学术论文80余篇;作为核心发明人申请抗衰老和抗肿瘤小分子专利5项;参编著作《Senolytics in Disease, Ageing and Longevity》和《发育生物学》;承担国家重点研发计划、国家自然科学基金、中国科学院和云南省基础研究等科研/人才项目10余项;担任《The Innovation》及《Aging and Disease》等杂志编委/青年编委。


学习和研究经历

2020.10 - 至今      中国科学院昆明动物研究所,研究员

2018.06 - 2020.09   美国佛罗里达大学(UF),药学博士后

2016.10 - 2018.05   美国阿肯色医科大学(UAMS),药学博士后

2013.01 - 2016.09   中国科学院昆明动物研究所,助理研究员、副研究员

2011.09 - 2012.09   加拿大国家研究委员会(NRC),中加联合培养博士

2007.09 - 2012.12   哈尔滨医科大学,医学博士学位

2002.09 - 2007.07   哈尔滨医科大学,医学学士学位


  研究方向

衰老是一个极其复杂的生物学性状,是老年疾病和死亡的独立危险因素。研究衰老的调控机制、开发有效的抗衰老手段,对认识衰老的本质、防治衰老相关疾病具有重大的科学和战略意义。课题组重点开展的研究方向有:


1衰老模型创建和干预靶点挖掘:以细胞、线虫、小鼠、树鼩和灵长类为主要研究对象,利用多种方式(自然衰老、物理和化学诱导衰老、癌基因诱导和早衰基因编辑)创建衰老和相关疾病模型;通过基因工程及药物化学手段,开发能动态监测个体衰老的新方法(Aging Cell. 2019Aging Cell. 2023);进一步,利用单细胞组学、分子生物学和功能学手段,构建衰老的关键调控网络(Genome Res. 2018),解析衰老及相关生物学性状的调控机制(Theranostics. 2017J Hematol Oncol. 2020a),并挖掘衰老及老年疾病(如肿瘤)的有效干预靶点(Nat Commun. 2020Aging Dis. 2023; Aging Cell. 2024)。


2抗衰老干预策略的开发:利用蛋白靶向降解嵌合体(PROTAC)(Oncogene. 2020Eur J Med Chem. 2020)、前药(Prodrug)、器官靶向干预(J Control Release. 2024)、基因编辑(CRISPR-Cas9AAV)和纳米酶等技术开发能有效清除衰老细胞/延缓细胞衰老的分子或策略(Mech Ageing Dev. 2021);此外,从天然植物中提取/筛选具有抗衰老活性的小分子(Mech Ageing Dev. 2019; Phytomedicine. 2024)。


3抗衰老干预在老年疾病和极端环境适应中的应用:衰老和老年疾病互为因果,共享诸多分子途径和功能靶点,抗衰老药物可有效防治老年疾病。除自然衰老外,极端环境也可诱发细胞应激和衰老。因此,我们主要针对肿瘤(J Hematol Oncol. 2020b)、纤维化疾病(Transl Res. 2019)和2型糖尿病等老年疾病(Aging Dis. 2024),以及极端环境(如低氧胁迫等)诱导的动物模型,开发能有效防治老年疾病和促进极端环境适应的先导分子。


  承担科研项目

[1] 国家重点研发计划子课题,2023YFC3603304,2023.12-2026.11,主持

[2] 云南省“兴滇英才支持计划”项目,2023-2027,主持

[3] 中国科学院率先行动“引才计划”青年项目,2022-2024,主持

[4] 云南省基础研究计划重点项目,202201AS070038,2022-2025,主持

[5] 国家自然科学基金面上项目,82171558,2022-2025,主持

[6] 国家自然科学基金面上项目,81671404,2017-2020,主持

[7] 云南省应用基础研究计划重点项目,2017FA038,2017-2020,主持

[8] 国家自然科学基金青年基金项目,81500670,2016-2018,主持

[9] 中科院青年创新促进会项目,2016-2019,主持

[10] 云南省应用基础研究计划面上项目,2013FB069,2013-2016,主持

[11] 国家重点基础研究发展计划项目,2013CB530802,2013-2017,课题骨干

  专家类别
研究员
  社会任职
2023年5月-至今,《Aging and Disease》青年编委
2023年11月-至今,“挑战杯”全国大学生课外学术科技作品竞赛评委
2022年10月-至今,《The Innovation》青年编委
2020年5月-2024年5月,《Current Cancer Drug Targets》编委
2021年2月-至今,中国老年医学学会-基础与转化医学分会委员
2021年5月-至今,中国生物物理学会-衰老生物学分会委员2020年10月-至今,中国营养学会-营养与组学分会常务委员
  获奖及荣誉

2023年 昆明动物所2023年度十大进展

2023年 云南省引进高层次人才(“兴滇英才支持计划”)

2022年 中国科学院引进海外高层次人才(中国科学院率先行动“引才计划”)

2020年 美国血液协会第61届学术年会研究报告成就奖

2016年 中国科学院青年创新促进会会员

2013年黑龙江省高校科学技术一等奖

2013年 黑龙江省科技进步二等奖

  代表论著

 (#共同一作,*共同通讯)

2024

[1] Zhang GQ, Samarawickrama PN, Gui L, Ma Y, Cao M, Zhu H, Li W, Yang HL, Li KC, Yang Y, Zhu EF, Li W*, He HY*. Revolutionizing Diabetic Foot Ulcer Care: The Senotherapeutic Approach. Aging and disease. 2024; doi: 10.14336/AD.2024.0065.

[2] Chen CJ#, Pan YZ#, Yang XY, Li HQ, Cai XH, He SY, Wang Q, Yang YW, Zheng RZ, Li HW, Yuan SJ, Dong X, Samarawickrama PN, Zi MT, He HY*, Zhang X*. Liver-targeting chimeras as a potential modality for the treatment of liver diseases. Journal of controlled release. 2024.

[3] Zhang YH#, Liu JH#, Zheng RZ, Hou KL, Zhang YD, Jia TX, Lu XY, Samarawickrama PN, Jia ST*, He HY*, Liu J*. Curcumin analogue EF24 prevents alveolar epithelial cell senescence to ameliorate idiopathic pulmonary fibrosis via activation of PTEN. Phytomedicine. 2024 (Accepted).

[4] Zeng M#, Zhou T#, Li ZY#, Li GM, Zhang SR, Wang L, Huang QG, Li JD, Samarawickrama PN, He HY*, Wang GD*. Transcriptomic and intervention evidence reveals domestic dogs as a promising model for anti-inflammatory investigation. Aging Cell. 2024; 23(5):e14127.

[5] Zhang X#, He HY#, Liu XG, Zhang X, Shi PZ, Wang YY, Zhou DH, Zheng GR*. Design and optimization of piperlongumine analogs as potent senolytics. Bioorg Med Chem Lett. 2024; 98:129593.

2023

[1] Hu L#, Dong CJ#, Wang Z, He SY, Yang YW, Zi MT, Li HQ, Zhang YH, Chen CJ, Zheng RZ, Jia ST, Liu J, Zhang X*, He YH*. A rationally designed fluorescence probe achieves highly specific and long-term detection of senescence in vitro and in vivo. Aging Cell. 2023; 22(8):e13896.

[2] Huang YQ#, Ge MX#, Li YH#, Li JL, Yu Q, Xiao FH, Ao HS, Yang LQ, Li J*, He YH*, Kong QP*. Longevity-associated transcription factor ATF7 promotes healthspan by suppressing cellular senescence and systematic inflammation. Aging and disease. 2023; 14(4):1374-1389.

[3] Xiao FH#, Wang HT#, Chen XQ, Ge MX, Yan DJ, Yang XL, Lin R, Guo RH, Zhang W, Tang NLS, He YH, Zhou JM, Cai WW*, Kong QP*. Hypermethylation in H3K9me3 regions characterizes the centenarian methylomes in healthy aging. National Science Review. 2023; 10(6): nwad067.

2022

[1] Guo LY#, Chen YJ#, Li HQ, Yin FQ, Ge MX, Hu L, Zi MT, Qin ZH, He YH*. Telomere length is maternally inherited and associated with lipid metabolism in Chinese population. Aging-US. 2022; 14(1):354-367.

[2] Hu L#, Li HQ#, Zi MT, Li W, Liu J, Yang Y, Zhou DH, Kong QP, Zhang YX*, He YH*. Why senescent cells (SnCs) are resistant to apoptosis: An insight for senolytic development. Frontiers in Cell and Developmental Biology. 2022; 10:822816.

[3] Xiao FH#, Yu Q#, Deng ZL#, Yang K, Ye YS, Ge MX, Yan DJ, Wang HT, Chen XQ, Yang LQ, Yang BY, Lin R, Zhang W, Yang XL, Dong L, He YH, Zhou JM, Cai WW*, Li Ji*, Kong QP*. ETS1 acts as a regulator of human healthy aging via decreasing ribosomal activity. Science Advances. 2022; 8(17):eabf2017.

2021

[1] Ge MX, Hu L, Ao HS, Zi MT, Kong QP*, He YH*. Senolytic targets and new strategies for clearing senescent cells. Mechanisms of Ageing and Development. 2021; 195:111468.

[2] He YH*,#, Li W*, Zhang JL, Yang Y, Qian YW, Zhou DH. The curcumin analog EF24 is highly active against chemotherapy-resistant melanoma cells. Current Cancer Drug Targets. 2021; 21(7):608-618.

2020

[1] He YH#, Zhang X(uan)#, Chang JH#, Kim H#, Zhang PY, Wang YY, Khan Sajid, Liu XG, Zhang X(in), Lv DW, Li W, Thummuri Dinesh, Yuan YX, Elisseeff Jennifer, Campisi Judith, Almeida Maria, Song L, Zheng GR*, Zhou DH*. Using Proteolysis-Targeting Chimera Technology to Reduce Navitoclax Platelet Toxicity and Improve Its Senolytic Activity. Nature Communications. 2020; 11(1):1996.

[2] He YH, Koch R, Budamagunta V, Zhang PY, Zhang X(uan), Khan S, Thummuri D, Ortiz Y. T, Zhang X(in), Lv DW, Wiegand J. S, Li W, Palmer A. C, Zheng GR, Weinstock D. M*, Zhou DH*. DT2216–a Bcl-xL specific degrader is highly active against Bcl-xL-dependent T-cell lymphomas. Journal of Hematology & Oncology. 2020; 13(1):95.

[3] He YH, Wen Li, Lv DW, Zhang Xin, Zhang X, Campisi Judith, Zheng GR, Zhou DH*. Inhibition of USP7 activity selectively eliminates senescent cells in part via restoration of p53 activity. Aging Cell. 2020; 19(3):e13117.

[4] He YH#, Khan S#, Huo ZG, Lv DW, Zhang X, Liu XG, Yuan YX, Hromas R, Xu MJ, Zheng GR, Zhou DH*. Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies. Journal of Hematology & Oncology. 2020; 13(1):103.

[5] He YH, Zheng GR, Zhou DH. Senolytic Drug Development. In: Senolytics in Disease, Ageing and Longevity. Healthy Ageing and Longevity. Springer, Cham. 2020; 11. doi: 10.1007/978-3-030-44903-2_1 (Book chapter)

[6] Khan S#, He YH#, Zhang X, Yuan YX, Pu SY, Kong QP, Zheng GR, Zhou DH*. PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics. Oncogene. 2020; 39(26):4909-4924.

[7] Zhang X#, He YH#, Zhang PY#, Budamagunta V, Lv DW, Thummuri D, Yang Y, Pei J, Yuan YX, Zhou DH*, Zheng GR*. Discovery of IAP-Recruiting BCL-XL PROTACs as Potent Degraders across Multiple Cancer Cell Lines. European Journal of Medicinal Chemistry. 2020; 199:112397.

[8] Kim HN#, Xiong JH#, MacLeod RS, Iyer S, Fujiwara Y, Cawley KM, Han L,He YH, Thostenson JD, Ferreira E, Jilka RL, Zhou DH, Almeida M*, O'Brien CA*. Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence. JCI Insight. 2020; 5(19):e138815.

2019

[1] Khan Sajid#, Zhang X#, Lv DW#, Zhang Q, He YH, Zhang PY, Yuan YX, Liu XG, Thummuri Dinesh, Wiegand Janet, Ferrando Adolfo, Hromas Robert, Konopleva Maria, Zheng GR*, Zhou DH*. A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity. Nature Medicine. 2019; 25(12):1938-1947.

[2] He YH, Thummuri D, Zheng GR, Okunieff P, Citrin DE, Vujaskovic Z, Zhou DH*. Cellular Senescence and Radiation-induced Pulmonary Fibrosis. Translational Research. 2019; 209:14-21.

[3] Yu Q, Pu SY, Wu H, Chen XQ, Jiang JJ, Gu KS, He YH*, Kong QP*. TICRR Contributes to Tumorigenesis through Accelerating DNA Replication in Cancers. Front Oncol. 2019; 9:516.

[4] Li W#, Qin L#, Feng RN, Hu GR, Sun H, He YH*, RP Zhang*. Emerging senolytic agents derived from natural products. Mechanisms of Ageing and Development. 2019; 181:1-6.

2018

[1] Xiao FH#, Chen XQ#, Yu Q#, Ye YS#, Liu YW, Yan DJ, Yang LQ, Chen GJ, Lin R, Yang LP, Liao XP, Zhang W, Zhang W, Wang XF, Zhou JM*, Cai WW*, He YH*, Kong QP*. Transcriptome evidence reveals enhanced autophagy-lysosomal function in centenarians. Genome Research. 2018; 28(11):1601-1610.

[2] He YH*, Li Wen, Hu GR, Kong QP. Bioactivities of EF24, a novel curcumin analog: A review. Frontiers in Oncology. Front Oncol. 2018; 11(8):614.

[3] Yuan LF, Zhai LH, Qian LL, Huang D, Ding Y, Xiang HD, Dr. Liu XJ, Thompson W, Liu J, He YH, Chen XQ, Hu J, Kong QP, Tan MJ, Wang XF*. Switching off IMMP2L Signaling Drives Senescence via Simultaneous Metabolic Alteration and Blockage of Cell Death. Cell Research. 2018; 28(6):625-643.

[4] Zhang X, Zhang SP, Liu XG, Wang YY, Chang JH, Zhang X, Mackintosh S, Tackett A, He YH, Lv DW, Laberge RM, Campisi J, Wang JR, Zheng GR, Zhou DH*. Oxidation resistance 1 is a novel senolytic target. Aging Cell. 2018; 17(4):e12780.

2017

[1] Li QG#, He YH#, Wu H#, Yang CP, Pu SY, Fan SQ, Jiang LP, Shen QS, Wang XX, Chen XQ, Yu Q, Li Y, Sun C, Wang XT, Zhou JM, Li HP, Chen YB*, Kong QP*. A normalization-free and nonparametric method sharpens pan-cancer expression analysis. Theranostics. 2017; 7(11):2888-2899.

2016

[1] He YH#, Chen XQ#, Yan DJ, Xiao FH, Lin R, Liao XP, Liu YW, Pu SY, Yu Q, Sun HP, Jiang JJ, Cai WW*, Kong QP*. Familial longevity study reveals a significant association of mitochondrial DNA copy number between centenarians and their offspring. Neurobiology of Aging. 2016; 47:218.e11-218.e18.

[2] He YH#, Lu X#, Tian JY, DJ Yan, Li YC, Lin R, Perry B, Chen XQ, Yu Q, Cai WW*, Kong QP*. Mitochondrial DNA contributes equally to female and male longevity in Chinese centenarians. Experimental Gerontology. 2016; 83:94-96.

[3] Xiao FH, Kong QP, Perry B, He YH*. Progress on the role of DNA methylation in aging and longevity. Briefings in Functional Genomics. 2016; 15(6):454-459.

[4] Han LY, Liu YF, Duan SW, Perry B, Li W*, He YH*. DNA methylation and hypertension: emerging evidence and challenges. Briefings in Functional Genomics. 2016; 15(6):460-469.

[5] Jiang JJ, Cheng LH, Wu H, He YH*, Kong QP*. Insights into long noncoding RNAs of naked mole rat (Heterocephalus glaber) and their potential association with cancer resistance. Epigenetics & Chromatin. 2016; 9:51.

2015

[1]He YH, Chen XQ, Yan DJ, Xiao FH, Liu YW, Lin R, Liao XP, Cai WW*, Kong QP*. Thyroid function decreases with age and may contribute to longevity in Chinese centenarians’ families. J Am Geriatr Soc. 2015; 63(7):1474-1476.

2014

[1]He YH, Lu X, Wu H, Cai WW*, Yang LQ, Sun HP, Kong QP*. MtDNA content contributes to healthy aging in Chinese: a study from nonagenarians and centenarians. Neurobiology of Aging. 2014;35(7):1779.e1-1779.e14.

[2]He YH, Zhang YX, Yang LQ, Liao XP, Cai WW*, Kong QP*.Assessment of the health status of centenarians in the South of China: A cross-sectional study.J Am Geriatr Soc. 2014;62(7):1402-1404.

[3]He YH, Lu X, Yang LQ, Xu LY, Kong QP*. Association of the insulin-like growth factor binding protein 3 (IGFBP-3) polymorphism with longevity in Chinese nonagenarians and centenarians. Aging-US. 2014; 6(11):944-56.

2013

[1] He YH, Li Y, Zhang SC, Perry B, Zhao TT, Wang YW*, Sun CH*. Radicicol, a heat shock protein 90 inhibitor, inhibits differentiation and adipogenesis in 3T3-L1 preadipocytes. Biochemical and Biophysical Research Communications. 2013; 436:169-174.

[2] He YH, Perry B, Bi MX, Sun H, Zhao TT, Li Y*, Sun CH*. Allosteric regulation of the calcium-sensing receptor in obese individuals. International Journal of Molecular Medicine. 2013; 32:511-518.

[3] He YH, Li Y, Zhao TT, Wang YW*, Sun CH*. Ursolic acid inhibits adipogenesis in 3T3-L1 adipocytes through LKB1/AMPK pathway. PLoS One. 2013; 8: 8(7):e70135.

2012

[1] He YH, Li ST, Wang YY, Wang G, He Y, Liao XL, Sun CH*, Li Y*. Postweaning low-calcium diet promotes later-life obesity induced by a high-fat diet. Journal of Nutritional Biochemistry. 2012; 23:1238-1244.

2011

[1] He YH, Song Y, Liao XL, Wang L, Li G, Alima, Li Y*, Sun CH*. The calcium-sensing receptor affects fat accumulation via effects on antilipolytic pathways in adipose tissue of rats fed low-calcium diets. Journal of Nutrition. 2011; 141(11):1938-46.

[2] He YH, Li ST, Wang YY, Wang G, He Y, Liao XL, Sun CH*, Li Y*. Postweaning low-calcium diet promotes later-life obesity induced by a high-fat diet. Journal of Nutritional Biochemistry. 2011; 23:1238-1244.

知识产权

[1] Zheng GR, Zhou DH, Zhang X, Khan S, He YH, Zhang PY. BCL-2 proteins degraders for cancer treatment. WO/2019/1441172019. 2019.

[2] Zhou DH, He YH, Zheng GR, Zhang X. USP7 inhibitor as potential senolytic agent and its applications. 052592-590174. 2018.

[3] Zhou DH, Zheng GR, He YH, Pi LY. Methods of treating diseases associated with senescent cell accumulation. WO2023064326A1. 2023.

[4] 何永捍,张翾,董婵娟,胡丽,王哲,何胜源. 一种靶向衰老细胞的近红外生物探针及其制备方法与用途. 202211569064.4. 2023.

[5] 何永捍,刘静,张阳焕,刘嘉华. 姜黄素类似物EF24 在制备治疗特发性肺纤维化药物中的用途. 202311445151.3


  研究团队

工作人员

董  鑫   博士后

白绕仙   博士后

罗秋妮   科研助理

字美婷   科研秘书


在读研究生

张  妍  2024级博士研究生

潘永涨  2024级博士研究生

杨鹏云  2024级博士研究生

Ayesha Nisar  2023级博士研究生

胡  丽  2022级博士研究生

任弼鸽  2024级硕士研究生

张  奥  2023级硕士研究生

曾清华  2023级硕士研究生(安徽师范大学联合培养)

周  朕  2022级硕士研究生

袁胜杰  2022级硕士研究生

Priyadarshani Nadeeshika Samarawickrama  2022级硕士研究生

Naheemat Modupeola GOLD  2022级硕士研究生

Copyright © 2018- 中国科学院昆明动物研究所 .All Rights Reserved
地址:云南省昆明市五华区教场东路32号  邮编:650223
电子邮件:zhanggq@mail.kiz.ac.cn  滇ICP备05000723号